46,544 Shares in Bath & Body Works, Inc. $BBWI Acquired by Aigen Investment Management LP

Aigen Investment Management LP purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the fourth quarter, Holdings Channel reports. The firm purchased 46,544 shares of the company’s stock, valued at approximately $935,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. lifted its holdings in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the period. Danske Bank A S acquired a new stake in shares of Bath & Body Works in the 3rd quarter valued at approximately $39,000. Global Retirement Partners LLC acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $32,000. Finally, Advisory Services Network LLC acquired a new stake in shares of Bath & Body Works in the 3rd quarter valued at approximately $48,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on BBWI. Deutsche Bank Aktiengesellschaft lifted their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Telsey Advisory Group reduced their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. UBS Group reduced their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Finally, Barclays reduced their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $21.93.

Check Out Our Latest Stock Report on BBWI

Bath & Body Works Stock Up 0.0%

NYSE BBWI opened at $19.40 on Monday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $33.96. The stock has a market cap of $3.91 billion, a price-to-earnings ratio of 5.45, a price-to-earnings-growth ratio of 1.93 and a beta of 1.42. The business has a fifty day moving average of $18.61 and a 200-day moving average of $20.11.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, June 5th. This represents a $0.80 annualized dividend and a yield of 4.1%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.